Search for: "Application of Johnson" Results 1461 - 1480 of 4,129
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Mar 2008, 5:47 am
  Risperidone is an antipsychotic medication sold by Janssen Pharmaceutica (a subsidiary of Johnson & Johnson) under the trade-name Risperdal ®. [read post]
  After canvassing the many faces of native advertising and the applicable law, the series ultimately examines the pervasive assumption that all native advertising is, and should be regulated as, “commercial speech. [read post]
8 Jan 2024, 3:17 am by Robin E. Kobayashi
Applicant then filed a petition for reconsideration, asserting that the MOH of the 12/29/22 trial was incorrect and factually incomplete, and that the Appeals Board had obstructed the Applicant’s due process rights by not interviewing percipient witnesses to the trial proceedings. [read post]
1 Feb 2023, 12:00 am by Jonathan Ross (Bristows)
  Finally, the Court considered an application from Neo to introduce new arguments and associated evidence. [read post]
23 Sep 2019, 9:30 am by Jacob Schulz, William Ford
The committee will hear testimony from a number of witnesses, including Diana Shaw, the assistant inspector general for reviews and evaluations at the department of homeland security (DHS); Peter Mina, the deputy officer for programs and compliance at DHS; and Tae Johnson, the assistant director for custody management, enforcement and removal operations at immigration and customs enforcement. [read post]
28 Mar 2021, 4:41 pm by INFORRM
On Wednesday and Thursday 24 and 25 March 2021 Julian Knowles J heard an application in the case of Kumlin v Jonsson. [read post]
10 Jan 2024, 8:05 pm by John Elwood
Johnson, which has gained some media attention. [read post]
24 May 2012, 1:02 pm by Kara M. Maciel
Johnson & Johnson, the Third Circuit Court of Appeals found that the named plaintiff formulated and implemented strategies for her territory, and thus exercised sufficient independent discretion to qualify for the Administrative exemption. [read post]
1 May 2009, 9:00 am
(IAM) US: Johnson & Johnson – 5 year exclusivity period would kill incentives to innovate (Patent Docs) US: CHI CEO on patent reform and follow-on biologics legislation (Patent Docs) US: BIO urges Congress on patent reform: First, do no harm (Patent Baristas) US: Pharmaceutical advertising: How to use a domain name to circumvent application of law (Domain Name / Nom De Domaine!) [read post]